7 completed, 4 unknown, 2 terminated, 1 active not recruiting. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 7, Unknown 4, Terminated 2, Active not recruiting 1, Withdrawn 1 |
Follow Spondyloarthritis: new trials by email Literature Review of Spondyloarthritis trials Research Report on Spondyloarthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing | Phase 4 | Active not recruiting | University of Sao Paulo General Hospital | 2005 | 2023-05-23 | 2026-05-04 |
| Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs Methotrexate, Sulfasalazine, Hydroxychloroquine - Ankylosing Spondylitis, Spondyloarthritis | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 100 | 2019-10-07 | 2019-09-26 |
| Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh Tofacitinib 5 mg,, Etanercept - Spondyloarthritis | Phase 4 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 174 | 2018-01-16 | 2018-04-23 |
| Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Golimumab, Placebo - Spondyloarthritis | Phase 4 | Completed | Merck Sharp & Dohme LLC | 323 | 2017-11-07 | 2023-07-28 |
| Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis TNF Inhibitor - Spondyloarthritis, Enthesitis | Phase 4 | Completed | Gunay ER | 31 | 2017-01-01 | 2021-07-08 |
| Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease 13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine - Rheumatoid Arthritis, Systemic Lupus | Phase 4 | Completed | Region Skane | 300 | 2016-06-14 | 2023-03-29 |
| The NOR-SWITCH Study Innovator infliximab, Biosimilar infliximab - Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Completed | Diakonhjemmet Hospital | 482 | 2014-10-01 | 2017-09-25 |
| Comparative Analysis of Two Therapeutic Strategies in Patients With Spondyloarthritis Treated With Anti-tnf Biologics anti drug antibodies dosage - Spondyloarthritis | Phase 4 | Terminated | University Hospital, Rouen | 8 | 2014-05-01 | 2017-06-15 |
| Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein 50mg Yisaipu, 25mg etanercept, Placebo - Spondyloarthritis | Phase 4 | Completed | Sun Yat-sen University | 150 | 2014-02-10 | 2019-12-19 |
| Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Adalimumab - Spondyloarthritis, Enterocolitis | Phase 4 | Completed | Regionshospitalet Silkeborg | 30 | 2010-10-01 | 2014-12-02 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Anti-pandemic H1N1 influenza vaccine - Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Unknown | University of Sao Paulo | 5000 | 2010-04-01 | 2010-06-28 |
| Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis Adalimumab, Placebo - Spondyloarthritis | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 49 | 2009-12-01 | 2019-01-04 |
| Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Adalimumab - Spondyloarthritis, Crohn's Disease | Phase 4 | Withdrawn | University of Alberta | 2009-07-01 | 2016-09-16 | |
| Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab) - SPONDYLOARTHRITIS | Phase 4 | Terminated | Glostrup University Hospital, Copenhagen | 7 | 2008-03-01 | 2015-08-19 |
| Danish Multicenter Study of Adalimumab in Spondyloarthritis Adalimumab, Placebo - Spondyloarthritis | Phase 4 | Unknown | Glostrup University Hospital, Copenhagen | 52 | 2006-02-01 | 2012-03-28 |
Spondylarthritis (15) · Arthritis, Rheumatoid (4) · Sjogren's Syndrome (3) · Spondylitis, Ankylosing (3) · Systemic Vasculitis (3) · Arthritis, Juvenile (2) · Crohn Disease (2) · Dermatomyositis (2) · Lupus Erythematosus, Systemic (2) · Scleroderma, Systemic (2) · Antiphospholipid Syndrome (1) · Arthritis, Psoriatic (1) · Behcet Syndrome (1) · Colitis, Ulcerative (1) · Enterocolitis (1)
Arthritis (15) · Bone Diseases (15) · Joint Diseases (15) · Musculoskeletal Diseases (15) · Spinal Diseases (15) · Spondylitis (15) · Autoimmune Diseases (4) · Connective Tissue Diseases (4) · Immune System Diseases (4) · Skin and Connective Tissue Diseases (4) · Spondylarthropathies (4) · Ankylosis (3) · Axial Spondyloarthritis (3) · Cardiovascular Diseases (3) · Digestive System Diseases (3)
Adalimumab (5) · Etanercept (4) · 13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Anbainuo protein, human (1) · CT-P13 (1) · Hydroxychloroquine (1) · Infliximab (1) · Methotrexate (1) · Pneumococcal Vaccines (1) · Sulfasalazine (1) · Tumor Necrosis Factor Inhibitors (1) · golimumab (1) · tofacitinib (1)
Glostrup University Hospital, Copenhagen (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Copenhagen University Hospital, Rigshospitalet (1) · Diakonhjemmet Hospital (1) · Gunay ER (1) · Merck Sharp & Dohme LLC (1) · Nanfang Hospital, Southern Medical University (1) · Region Skane (1) · Regionshospitalet Silkeborg (1) · Sun Yat-sen University (1) · University Hospital, Rouen (1) · University of Alberta (1) · University of Sao Paulo (1) · University of Sao Paulo General Hospital (1)
Denmark (4) · Brazil (2) · China (2) · Bangladesh (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Netherlands (1) · Norway (1) · Poland (1) · Romania (1) · Russia (1) · Spain (1) · Turkey (Türkiye) (1)
Susanne J Pedersen, MD (2) · Bent Deleuran, M.D. (1) · Henning Glerup, M.D. (1) · Jehns Martineus, MD (1) · Jieruo Gu, Professor (1) · Jun Xiao (1) · Mikkel Ostergaard, Professor (1) · Shaikh A Al Mamun, MBBS (1)
PMID 21540203, PMID 21859696, PMID 22089462, PMID 22298793, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23525305, PMID 23818263, PMID 24961747, PMID 26414004, PMID 28502609, PMID 28968874, PMID 29556419, PMID 30762274, PMID 30936290, PMID 32087733, PMID 32965617, PMID 36919768, PMID 41679320, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284
2014 (1), 2015 (1)